The new powers of the U.S. Food and Drug Administration (FDA) to regulate tobacco were expected to precipitate an avalanche of petitions to approve reduced-risk cigarettes, from an industry long rumored to have wondrous novelties up its sleeves, ready to be deployed at the first chance of legality. Alas, so far the industry has been remarkable for a deafening silence. What could be the matter?
展开▼
